EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular medicine-based IBD treatment strategies—we take it personally!

Viktoria Hentschel, Jochen Klaus

Frontiers in Gastroenterology · 09.08.2023 · 2

DOI: 10.3389/fgstr.2023.1226048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 09.08.2023. Verfasst von Viktoria Hentschel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Clinic Ulm, Ulm, Germany. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In light of potentially aggressive disease courses of either IBD type—CD or UC—marked by frequent flareups or non-subsiding inflammatory activity, effective immunosuppression is key to preventing progressive tissue destruction and permanent disability. However, over-treating patients with a high probability of an indolent disease course ought to be avoided. To solve this therapeutic dichotomy, there is a pressing need for a reliable classification of patients based on their biosignature to rate their individual prognosis and likelihood of response to a given therapy. This need for pinpoint therapeutic strategies is addressed by the concepts of PreM and the more stringently defined PerM. In this review we summarize the most pivotal study results published so far in the field of individualized IBD care with a special focus on molecular diagnostics and their applicability in the clinical setting.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseasebiomarkerpersonalized medicine (PM)prediction of response to therapyulcerative colitis

Autor:innen und Institutionen

  • Department of Internal Medicine I, University Clinic Ulm, Ulm, Germany.

Zitieren

APA

Hentschel, V., & Klaus, J. (2023). Molecular medicine-based IBD treatment strategies—we take it personally!. Frontiers in Gastroenterology, 2. https://doi.org/10.3389/fgstr.2023.1226048

Vancouver

Hentschel V, Klaus J. Molecular medicine-based IBD treatment strategies—we take it personally!. Frontiers in Gastroenterology. 2023;2. doi:10.3389/fgstr.2023.1226048

BibTeX
@article{Hentschel2023,
  author = {Hentschel, Viktoria and Klaus, Jochen},
  title = {Molecular medicine-based IBD treatment strategies—we take it personally!},
  journal = {Frontiers in Gastroenterology},
  year = {2023},
  volume = {2},
  doi = {10.3389/fgstr.2023.1226048}
}
Kostenlos starten →